The utilization of copper(II) phosphate for the anodic stripping voltammetric assay of alendronate sodium, desferrioxamine mesylate and lisinopril

Talanta

Volumn 59, Issue 5, 2003, Pages 1061-1069

  Razak, O Abdel ^a   Belal, S F ^a   Bedair, M M ^a   Haggag, R S ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Anodic stripping voltammetry; Copper(II) labile complex; Pharmaceutical preparations; Plasma

Indexed keywords

DRUG PRODUCTS; PLASMAS; SODIUM; STATISTICAL METHODS; SUSPENSIONS (FLUIDS);

ANODIC STRIPPING VOLTAMMETRY;

COPPER COMPOUNDS;

ALENDRONIC ACID; COPPER COMPLEX; COPPER PHOSPHATE; DEFEROXAMINE MESYLATE; LISINOPRIL; UNCLASSIFIED DRUG;

ANODIC STRIPPING POTENTIOMETRY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG BLOOD LEVEL; DRUG FORMULATION; PARAMETER;

EID: 0037431152     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-9140(03)00013-4     Document Type: Article

References (33)

1. E.W. Tsai, S.D. Chamberlin, R.J. Forsyth, C. Bell, D.P. Ip, M.A. Brooks, J. Pharm. Biomed. Anal. 12 (8) (1994) 983.
2. Y.H.R. Han, X.Z. Qin, J. Chromatogr. A 719 (2) (1996) 345.
3. X.Z. Qin, E.W. Tsai, T. Sakuma, D.P. Ip, J. Chromatogr. A 686 (2) (1994) 205.
4. British Pharmacopoeia, Her Majesty's Stationery Office, London, 1998.
5. The United States Pharmacopeia, Twenty Fourth Revision, The National Formulary, Nineteenth Revision, United States Pharma-copeial Convention, Inc., 2000.
6. S. Igarashi, K. Yoshida, T. Yotsuyangi, Bunseki Kagaku 40 (10) (1991) 571.
7. A.S. Roque da Silva, A.M. Roque da Silva, Rev. Port. Farm. 38 (3) (1988) 41.
8. A.S. Roque da Silva, A.M. Roque da Silva, Rev. Port. Farm. 39 (1) (1989) 9.
9. S. Venkataram, Y.E. Rahman, J. Chromatogr. 18 (411) (1987) 494.
10. R.A. Romero, J.P. Day, Trace Elem. Med. 2 (1) (1985) 1.
11. P. Menendez-Fraga, E. Blanco-Gonzalez, A. Sanz-Medel, J.B. Cannata-Andia, Talanta 45 (1) (1997) 25.
12. H.J. Kraemer, H. Breithaupt, J. Chromatogr. B 710 (1-2) (1998) 191.
13. J.D. Glennon, A.T. Senior, J. Chromatogr. B 92(2 (J. Chromatogr. 527)) (1990) 481.
14. R.J. Speirs, G.L. Boyer, J. Chromatogr. 537 (1-2) (1991) 259.
15. S. Singh, N. Mohammed, R. Ackerman, J.B. Porter, R.C. Hider, Anal. Biochem. 203 (1) (1992) 116.
16. P. Allain, Y. Mauras, G. Beaudeau, P. Hingouet, Analyst 111 (5) (1986) 531.
17. P.C. D'Haese, L.V. Lamberts, M.E. De Broe, Clin. Chem. 35 (5) (1989) 884.
18. S. Bourdon, P. Houze, P.R. Bourdon, Clin. Chem. 33 (1) (1987) 132.
19. S. Singh, R.C. Hider, J.B. Porter, Anal. Biochem. 187 (2) (1990) 212.
20. P. Ip Dominic, D. Joseph DeMarco, A. Marvin Brooks, Lisinopril, in: K. Florey (Ed.), Analytical Profiles of Drug Substances, vol. 21, Academic Press, New York, 1992, p. 233.
21. A.B. Avadhanulu, A.R.R. Pantulu, Indian Drugs 30 (12) (1993) 646.
22. F.A. El-Yazbi, H.H. Abdine, R.A. Shaalan, J. Pharm. Biomed. Anal. 19 (6) (1999) 819.
23. D. Ozer, H. Senel, J. Pharm. Biomed. Anal. 21 (3) (1999) 691.
24. R. Gotti, V. Andrisano, V. Cavrini, C. Bertucci, S. Fulanetto, J. Pharm. Biomed. Anal. 22 (3) (2000) 423.
25. H.J. Leis, G. Fauler, G. Raspotnig, G.W. Windischhofer, Rapid Commun. Mass Spectrom. 13 (8) (1999) 650.
26. H.J. Leis, G. Fauler, G. Raspotnig, W. Windischhofer, Rapid Commun. Mass Spectrom. 12 (21) (1998) 1591.
27. Y.C. Wong, B.G. Charles, J. Chromatogr. B 673 (2) (1995) 306.
28. A.S. Yuan, J.D. Gilbert, J. Pharm. Biomed. Anal. 14 (7) (1996) 773.
29. H.H. Willord, Instrumental Analysis, D. Van Nostrand Company, New Jersy, Toronto, London, 1967, p. 693.
30. W.J. Blaedel, J.W. Todd, Anal. Chem. 32 (3) (1960) 1019.
31. C.M.G. Van den Berg, Analyst 117 (1992) 589.
32. J. Labuda, D. Saur, D.R. Neeb, Fresenius J. Anal. Chem. 349 (1994) 294.
33. C. Dollery, Therapeutic Drugs, Churchill Livingstone, Edinburgh, London, New York, Philadelphia, San Francisco, Sydney, Toronto, 1999.